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sensus with a third reviewer where necessary.
Inclusion criteria were: a) randomised controlled trials (RCT), pro-
spective cohort studies (PCS) or case control studies (CCS); b) including
adults over 45 years old with knee pain or OA; c) undertaking exercise
or physical activity explicitly over at least three months; and d) meas-
uring a safety related outcome including adverse events, pain, physical
functioning, radiographic or magnetic resonance imaging (MRI) OA
biomarker progression or progression to total knee replacement (TKR).
Included studies were assessed for risk of bias using the Cochrane risk of
bias tool for RCT and the Quality In Prognosis Studies risk of bias tool for
PCS and CCS. Safety data were extracted and analysed by narrative
synthesis.
Results: In total, 8605 unique references were identiﬁed by the search
and 37 primary studies were included in the review. The included
studies were made up of 35 RCT, 1 PCS and 1 CCS, which were under-
taken in 16 different countries and were of variable quality. In total,
7194 older adults with either knee pain or clinical, radiographic and
combined OA diagnoses were included. The 35 RCT investigated a
variety of exercise and physical activity interventions including: walk-
ing, Tai Chi, aerobics, strengthening, ﬂexibility, balance, and exercise in
water, of between three months and two years duration. 15 studies
provided data on adverse events, 35 on pain, 32 physical functioning
and 5 some form of radiographic orMRI biomarker of OA progression. In
terms of safety results, only eight serious adverse events were reported:
one inguinal hernia, ﬁve falls (one of which resulted in a head laceration
injury and one a fractured radius), one participant fractured her foot as a
result of dropping a weight and one had an exacerbation of existing
back pain. Mild adverse events of increase in knee pain occurred in a
minority of individuals in eight RCT. There was no evidence of a stat-
istically signiﬁcant increase in pain, decrease in physical function, or
deterioration in radiographic or MRI ﬁndings (compared to either
control group at follow up orwithin the same group comparing baseline
to post treatment data). The single, moderate risk of bias, CCS inves-
tigated factors associated with OA progression to TKR in Finnish older
adults. It concluded that increasing levels of regular exercise were
associated with less chance of progression when compared to those
who did not carry out regular exercise. The single, high risk of bias, PCS
investigated occupational physical activity exposure in older adult
members of a French energy company. From a set of 10 physical activity
variables, only prolonged exposure to kneeling and squatting activities
(between 1 and 25 years) was associated with severe knee pain
(Adjusted OR 1.4 95% CI 1.04,1.85). Overall risk of bias across studies was
variable with performance, attrition, and reporting bias frequently
being unclear.
Conclusions: This systematic review demonstrates that long-term
exercise and physical activity, lasting three months or more, is safe for
older adults with existing knee pain or OA. Serious adverse events with
exercise are very rare. However, the risk of bias of included studies was
often a concern.
These ﬁndings match existing expert consensus regarding the safety of
exercise and current recommendations for exercise and physical
activity as “core” treatments in clinical guidelines.
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BIOACTIVITY IN AN AGGRECAN 32MER FRAGMENT IS MEDIATED VIA
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Purpose: One naturally-occurring fragment of aggrecan catabolism is
the 32mer fragment derived from the aggrecan interglobular domain
following cleavage by both ADAMTS and MMP enzymes. The aim of this
study was to determine whether the aggrecan 32mer fragment was
bioactive, and if so, to elucidate the mechanism.
Methods: Mouse femoral head cartilage explants, epiphyseal chon-
drocytes, synovial ﬁbroblasts or peritoneal macrophages were cultured
for 24 hours in the presence of synthetic mouse 32mer (FFGVGGED-
DITIQTVTWPDLELPLPRNVTEGE; Auspep, Australia) or a scrambled
peptide comprising the same amino acids in a random order. Global
gene expression in explants treated with IL-1a or 32mer was compared
on Illumina mouse W6-6_V2 expression beadchips. Thereafter, changesin gene and protein expression were validated in cell and explant cul-
tures by qPCR, IL-6 ELISA and gel zymography.
Results: In the microarray experiment, 32mer-treated cartilage
explants decreased their expression of genes encoding matrix proteins
and increased their expression of pro-inﬂammatory/pro-catabolic
genes. The results showed that the pattern of genes that were up- and
down-regulated by IL-1a and 32mer treatment were strikingly similar.
Validation by qPCR conﬁrmed that the 32mer, but not a scrambled
32mer peptide, regulated gene expression in articular chondrocytes,
peritoneal macrophages and synovial ﬁbroblasts from wildtype mice.
The levels of IL-6 measured by ELISA and gelatinase activity measured
by gel zymography were also signiﬁcantly increased in cells treated
with 32mer or IL-1a, but not the scrambled peptide. The striking cor-
relation in the pattern of genes regulated by IL-1a and 32mer treatment
raised the possibility that IL-1a and the 32mer might share components
of a signalling pathway; for example MyD88 is an essential adaptor
protein for both the IL-1 receptor andmost Toll-like receptors (TLR). We
therefore compared cells from wildtype mice and MyD88 null mice for
the effects of 32mer stimulation and found that neither gene expression
nor levels of IL-6 cytokine were increased in cells harvested from mice
lacking MyD88, suggesting that the 32mer might be an activator of TLR
signalling. We next compared the effect of 32mer treatment on mac-
rophage cell lines derived from wildtype, TLR2 or TLR4 null mice and
found that whereas stimulation with the 32mer was identical in wild-
type and TLR4 null cells, the 32mer failed to signal in TLR2 null cells.
These results strongly suggest that the aggrecan 32mer is a ligand for
TLR2. We next used complementary hydropathy to derive an antigenic
sequence for raising an antibody (aCG11) against a putative 32mer-
binding protein, then used aCG11 immunoafﬁnity chromatography to
isolate the putative 32mer-binding protein from 4M GuHCl extracts of
human OA and juvenile cartilage. Mass spectrometry analyses identi-
ﬁed PRELP, a small leucine-rich repeat proteoglycan, as the major
molecule binding to and eluting from the immunoafﬁnity column in
both samples, and this was conﬁrmed byWestern blotting with aPRELP
antibodies. Decorin and biglycan are also members of the small leucine-
rich repeat proteoglycan family; they are related to PRELP, and both
have been identiﬁed as TLR2 and TLR4 ligands. Further experiments to
resolve the biological role of PRELP in 32mer-mediated TLR activation in
chondrocytes, synovial ﬁbroblasts and macrophages are in progress.
Conclusions: These studies identify the aggrecan 32mer as an endog-
enous activator of TLR2-mediated immunity with the potential to
accelerate inﬂammation and cartilage destruction in vivo.
11
DECORIN-DEFICIENT MICE ARE LESS PRONE TO DEVELOP
OSTEOARTHRITIS AFTER FORCED EXERCISE
T. Gronau y, U. Hansen z, D.G. Seidler z, R.V. Iozzo x, A. Aszodi k,
C. Prein{, H. Clausen-Schaumann{, K. Kr€uger#, F.C. Mooren#,
J. Bertrand y, T. Pap y, P. Bruckner z, R. Dreier z. y Inst. of Experimental
Musculoskeletal Med., Univ. Hosp. M€unster, M€unster, Germany; z Inst. for
Physiological Chemistry, Univ. Hosp. M€unster, M€unster, Germany;
xDepatment of Pathology, Thomas Jefferson Univ., Philadelphia, PA, USA;
k Experimental Surgery and Regenerative Med., Ludwig-Maximilians-
Univ. Munich, Munich, Germany; {Dept. of Applied Sci. and
Mechatronics, Munich Univ. of Applied Sci., Munich, Germany; # Inst. of
Sports Med., Justus-Liebig Univ. Giessen, Giessen, Germany
Purpose: Here we analyzed the impact of decorin-deﬁciency (Dcn-/-)
on the biomechanical properties of cartilage and the osteoarthritis
development in a mouse model via forced exercise on a treadmill. In
articular cartilage, the small leucine-rich proteoglycan decorin (Dcn) is
located within the interterritorial regions of the extracellular matrix
(ECM), where it is associated with thick, well-banded collagen ﬁbrils.
Inside the ECM, decorin binds and inactivates TGF-b and thereby reg-
ulates the activity of this cytokine, which is known to inﬂuence the
sulfation of glycosaminoglycan (GAG) chains.
Methods: Osteoarthritis (OA) was induced in three month-old Dcn-/-
and WT mice via forced running on a treadmill and the severity was
scored by a modiﬁed Mankin score. To analyze biomechanical proper-
ties, knee cartilage of Dcn-/- mice and wild-type (WT) mice was
examined at different developmental stages by histology, immunohis-
tochemistry, and atomic force microscopy (AFM). The amount of active
TGF-b1 in the supernatant of cultured Dcn-/- andWTchondrocytes was
analyzed by ELISA. Expression of GAGmodifying enzymes was assessed
by semi-quantitative RT-PCR.
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articular cartilage after six weeks of forced running on a treadmill.
However, the changes were less severe in Dcn-/- compared to WT mice
(Mankin score 4.5 (Dcn-/-) versus 6.5 (WT)). In juvenile and adult, but
not newborn Dcn-/- mice, staining of cartilage for highly sulfated GAGs
via Alcian blue (pH 1.0) revealed an increased intensity compared to
WT mice. Likewise, the use of an antibody against chondroitin-4-sul-
fate (C4S) stubs (Δ) showed a comparably enhanced staining pattern in
Dcn-/- mice. In contrast, we found no differences in staining for pro-
teoglycan core proteins (e.g. aggrecan, biglycan, versican) or collagens
(II, VI, IX, X). At the mRNA-level, Dcn-/- mice exhibited an increased
expression of PAPS-synthase-1 (PAPSS-1), chondroitin-4-sulfo-
transferase-1 (C4ST-1) and chondroitin-4-sulfotransferase-2 (C4ST-2),
which are involved in GAG modiﬁcation. This was also true at the
protein level as visualized via staining for PAPSS-1 and ΔC4S. More-
over, AFM analysis of articular cartilage sections of three months-old
mice revealed an increased compressive stiffness of decorin-deﬁcient
articular cartilage. Those abnormalities were accompanied by
enhanced levels of active TGF-b1 in decorin-deﬁcient chondrocytes in
vitro.
Conclusions: We propose the following mechanism of OA-attenuation
in Dcn-/- mice: Decorin sequesters the cytokine TGF-b in the extrac-
ellular matrix. Higher levels of active TGF-b in cartilage of Dcn-/- mice
are likely to prevent inappropriate chondrocyte hypertrophy and,
hence, induction of osteoarthritis. TGF-b also triggers increased sulfa-
tion of GAG chains, via an upregulation of PAPSS-1, C4ST-1 and C4ST-2
and consequently a stiffer cartilage matrix. Therefore, decorin-deﬁcient
animals are less prone to develop osteoarthritis due to a combination of
elevated levels of TGF-b-activity and enhanced compressive stiffness of
the tissue.
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CTGF IS RELEASED FROM THE PERICELLULAR MATRIX OF ARTICULAR
CARTILAGE UPON MECHANICAL INJURY, AND CONTROLS THE
BIOAVAILABILITY OF TGFb
X. Tang, C. McLean, A. Chanalaris, T.L. Vincent. Univ. of Oxford, Oxford,
United Kingdom
Purpose: Work from our lab has identiﬁed an important role for the
pericellular matrix (PCM) in the mechanosensitive release of seques-
tered regulatory molecules such as FGF2. (Vincent et al. 2007). A pro-
teomic analysis of PCM proteins also identiﬁed connective tissue
growth factor (CTGF also known as CCN2). CTGF is signiﬁcantly elevated
in osteoarthritis (OA) (Hermansson et al. 2004) but its role in cartilage is
obscure. We investigated the control of the release of CTGF in cartilage,
and its biological function.
Methods: His-tagged human recombinant CTGF protein was stably
expressed in HEK293 cells and puriﬁed using nickel afﬁnity chro-
matography. To look for novel gene targets a microarray study was
performed on isolated human articular chondrocytes (HACs) with or
without CTGF stimulation. Target genes were validated by real time
PCR. Phosphorylation of SMADs was examined by western blot. The
dependence of SMAD phosphorylation and gene regulation on TGFb
was examined using a TGFb neutralising antibody and the TGFb type
I receptor inhibitor SB431542. For injury studies, porcine cartilage
was either explanted into serum free DMEM for up to 24h, or was
rested (48 hours) and then re-cut in fresh serum free DMEM for
different time periods. Both explantation and re-cut conditioned
media were collected and analysed under either reducing or non-
reducing conditions. Articular cartilage was examined by confocal
microscopy for CTGF and the latency associated peptide of TGFb
(LAP).
Results: In the microarray study, we identiﬁed four genes that were
strongly up-regulated by CTGF in human chondrocytes. All genes were
known to be TGFb inducible and their expression showed a similar
temporal pattern to TGFb. CTGF was able to activate SMAD2 in porcine
chondrocytes. Both CTGF induced gene expression and SMAD2 phos-
phorylation was abrogated by TGFb neutralising antibody and the
receptor inhibitor SB431542, suggesting that CTGF activity was TGFb
dependent. Adding exogenous CTGF to rested porcine cartilage for 1 or
4 hours, led to increased TGFb protein in the medium but no sig-
niﬁcant change in the mRNA level of TGFb. Injury to porcine cartilage
by explantation or re-cutting caused rapid massive accumulation of
endogenous CTGF in the conditioned medium (within 5 minutes),
followed by a delayed accumulation of TGFb (from 1 hour). Theaccumulation of both proteins in response to injury occurred in the
presence of cycloheximide, suggesting proteins were released from a
pre-formed pool rather than by new protein synthesis. When we
analysed the explantation conditioned medium under non-reducing
condition, CTGF was found to migrate at 150KDa along with compo-
nents of the latent TGFb complex (LAP). Although TGFb was not evi-
dent by western blot under non-reducing conditions, it was clearly
present when the same medium was run under reducing conditions
suggesting that TGFb was also tied up in the high molecular weight
complex. This was supported by the observation that the explantation
conditioned medium was able to activate SMAD2, and this activity
resided in a high molecular (>50kDa) fraction. Confocal microscopy
revealed that CTGF was present in the pericellular matrix as was the
latent complex of TGFb.
Conclusions: Our results show that pericellular CTGF, like FGF2, is
released from the matrix upon cartilage injury. The latent complex of
TGFb is also in the pericellular matrix and released with CTGF upon
injury. The temporal sequence suggests that CTGF is released ﬁrst and
then contributes to the release of latent TGFb, although it is possible
that both CTGF and TGFb are already bound and are released simulta-
neously upon injury. Either way we have described a novel pathway by
which cartilage injury controls the bioavailability of TGFb through
matrix bound CTGF.
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GALECTIN 3 HAD A PROTECTIVE ROLE IN MURINE OSTEOARTHRITIS
INDUCED BY MENISCECTOMY AND AGING
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Purpose: Osteoarthritis (OA) is the most common adult joint disease
characterized by cartilage destruction, subchondral bone remodelling
andmild synovial inﬂammation. Pathogenesis of OA involves mechanic,
age and genetic factors. Galectin 3 (Gal3) expression is increased in OA
cartilage and synovial ﬂuid. Gal3 is involved in multiple cellular func-
tions including proliferation, differentiation and cell death. During
embryogenesis, the growth plate of Gal3 mutant mice has a reduction of
hypertrophic zone and many lacunae due to a loss of chondrocytes.
These results suggest a role of Gal3 in chondrocyte differentiation. The
aim of this study is to determine the role of Gal3 in osteoarthritis and to
assess its functions in chondrocyte biology.
Methods: Invivo,murineOAwas induced inWild type (WT)129andGal3
mutant mice by partial medial meniscectomy (MNX) of the right knee. A
sham operationwas performed on the left knee. Animals were sacriﬁced
4 weeks after surgery. Cartilages lesions were assessed by according to
OARSI recommendations. Chondrocyte apoptosiswas assessed by TUNEL
labelling and chondrocyte catabolism by immunostaining for aggreca-
nases and metalloproteases. Subchondral bone modiﬁcations were
evaluated by microCT. In parallel, we assessed joint lesions durinbg
ageing in 14 month old mice. In vitro, primary murine chondrocytes,
isolated from new born WT and Gal3 mutant mice, were cultured and
stimulated by inﬂammatory cytokines (IL-1b and TNF-a). Anabolism,
catabolic and differentiation responses were assessed by RT-qPCR.
Results: In vivo, MNX induced in Gal3 mutant mice more severe OA
cartilage lesions compared to WT as assessed by OARSI scoring (4.43 
1.02 vs 1.30 0.77, p<0.05). Expression Gal3 decreased inWTcartilages
after MNX compared to sham operated cartilage (34.5%  4.9 vs 53% 
2.8; p<0.01). Cartilages lesions were associated with higher ratio of
chondrocyte positive-TUNEL staining in Gal3 mutant cartilages com-
pared to WT (17.7%  6.2 vs 10.6%  3.3 p<0.02). Similarly, immunos-
taining for ADAMTS-5 (26.7%  0.5 vs 16%  1.4, p<0.02) and VDIPEN
(52%  4 vs 30%  2 ; p<0.05) was increased in Gal3 mutant cartilages.
Moreover, collagen type X expression was increased in Gal3 mutant
cartilage. No difference was observed in subchondral bone mod-
iﬁcations. Finally, Gal3 mutant mice developed spontaneous OA carti-
lage lesions at 14 months old. In vitro, IL-1b stimulation increased
ADAMTS-4(4.58 1.97 vs; 1.60 0.28 ; p<0.05) and ADAMTS-5 (4.52
2.19 vs 1.78  1 ; p<0.05)mRNA expressions in Gal3 mutant chon-
drocytes compared to WT chondrocytes.
Conclusion: Gal3 deletion exacerbated murine OA lesions induced by
mechanical stress and by ageing. OA lesions were associated with
increased chondrocyte catabolism, differentiation and death. These
results suggested Gal3 had a protective role in OA and chondrocyte
homeostasis.
